Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
As requested:
1 Home Trial last patient dosed
2 Active2 Trial Confirmatiom ( operation warp speed) and US home trial
3 Manufacturing Upscale
4 Preliminary update on Phase3 progress ( Fda internal Committee)
5 Home Trial Readout
6 EUA approval(s)
7 SNG001 for patients on ventilators
8 TR1s ( additional IIinterest)
9 Govt(s) Preorders
10 Bid Offer(s)
Etc
https://newseu.cgtn.com/news/2021-01-14/UK-trials-interferon-beta-seeking-79-cut-in-severe-COVID-19-symptoms-X1HSGSToPu/index.html
https://pharmaphorum.com/news/synairgen-starts-dosing-inhaled-covid-19-drug-in-phase-3-trial/
Many would have expected a bigger rise but I guess some large orders had to be filled at certain levels.
We could see bigger percentages with not even half of the volume we had today in the coming days.
Eveything is moving according to plans, we had media coverage even in Canada and Active2 news has also finally landed.
Home trial will be the next significant piece of news together with the Active 2 trail inclusion.
We won't have to wait for weeks, it is now just a matter of days.
Therefore we can only build up from here testing the 2£ in January and then trading for new highs as early as next month during which EUA(s) might also arrive.
Feeling optimistic I could see the SP close to 3£ or above by the end of next month with the countdown for results already started.
Thanks everyone for your continuous research.
ATB
Correct.
Stocks don't go up in a straight line.
II doing their things in the background/ orders to be filled at a given price/ people who bought low last month taking some profits.
It's all part of the game.
Be Faithful!
There are four different types:
Common
Breakaway
Runaway
Exhaustion
Apart from today the other two were " breakaway" gaps so if you are still convinced that they will be filled I can tell you to think twice.
A breakaway gap occurs when prices are breaking out of a range on significant volume, developing a new trend.
As a result of a new trend bringing in new market participants and catching many off-sides, this gap generally does not fill and sees upside follow-through relatively quickly.
The less that it’s filled, the more clear that a strong new trend has developed.
So Mr Contrarian you might be wrong!
PS: I would like to see First Patient RNS tomorrow.
ATB
GLA
My take is that given that the CDC will assess and review how the trial is progressing after 200 patients are enrolled,
we could expect some preliminary data readout before the end of January.
At that time we should have completed enrollment for thr home trial as well. Considering TW said 40+ patients had been enrolled at the end of November, with an average of 2/3 per day it will take us to the end of January.
Presuming that positive news are released, Major headlines to be expected in January.
In conclusion, a steady rise in the SP can be expected from now on and with further developments we could see £3/4 plus sooner than we think.
ATB
For sure sooner than later.
And it will be a relief for those who bought at a higher price.
Buying at this level is still an excellent entry point for who is still undecided.
Looking forward to next week.
ATB
Great video charting update.
Source Share Talk.
Skio to the 7th minute.
Everyone should watch this.
https://www.share-talk.com/share-talk-bulletin-board-heroes-friday-18th-december-2020/#gs.nvdjc2
Completely agree CR1909
Things are moving forward in a positive way.
First patient dosed hopefully RNSed next week.
Trial sites ready for it..
FDA support and IND cleared.
Home trial in weeks.
Approval cards on the table.
Great future prospects for sales and revenue.
Looking forward to January and hope that 2021 will be a better year in all fronts.
ATB